The long-term goal of the Pilot Grant Program is to provide resources to COBRE investigators so that they can generate new, preliminary data for extramural grant applications and thus expand their research programs. The Pilot Grant Program was begun in Phase I, continued in Phase II and its success will be built upon in Phase III. During Phase I and II the Program was extremely successful. Awardees produced -200 publications and the success rate for gaining independent extramural funding was -80%. Many of the initial awardees have now been granted tenure. This successful program will continue in Phase III. The Pilot Grant Program will feature three grant categories, all designed to further the goals of the COBRE Center for Molecular Medicine and to promote innovation by allowing meritorious investigators to explore novel ideas and develop new technologies. Category 1 grants are for newly-independent, non-tenured, tenure-track research faculty with no prior NIH ROI or equivalent external grant support as a principal investigator. A strong mentoring component is associated with this class of grant. Category 2 grants are for more established faculty who wish to pursue a new research area for which they do not currently have an NiH R01 or equivalent. These grants are meant to promote innovation and allow investigators to expand their research programs into new areas. Category 3 grants are available to groups of investigators planning to submit a multi-PI or Program Project grant application working collaboratively on a specific research problem, and can be comprised of both junior and more established investigators. These grants are meant to promote synergistic collaborations. The grants are designed for 2 years of funding ($50,000 per year) with the second year contingent on demonstrated progress. Evaluation of the grant applications and funding decisions will be made by the External Advisory Board in consultation with the Program Coordinator. All applicants, regardless of funding decisions, will receive a review of their proposals with a full evaluation of NIH's five criteria so that their future proposals can be improved. This Pilot Grant program has had a highly successful past and its philosophy of operation will be carried into Phase III.

Public Health Relevance

The Pilot Grant Program promotes innovation by supporting COBRE investigators in the exploration of novel ideas and in the development of new technologies. This new knowledge will be the foundation for developing the future diagnostics tools and clinical therapeutics needed in the treatment of human disease.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Center Core Grants (P30)
Project #
1P30GM110787-01
Application #
8751199
Study Section
Special Emphasis Panel (ZGM1)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-04-30
Support Year
1
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of Kentucky
Department
Type
DUNS #
City
Lexington
State
KY
Country
United States
Zip Code
40506
Wachter, Erin; Moyá, Diego; Parkin, Sean et al. (2016) Ruthenium Complex ""Light Switches"" that are Selective for Different G-Quadruplex Structures. Chemistry 22:550-9
Meier, Shelby; Bell, Michelle; Lyons, Danielle N et al. (2016) Pathological Tau Promotes Neuronal Damage by Impairing Ribosomal Function and Decreasing Protein Synthesis. J Neurosci 36:1001-7
Xu, Xuehe; Watt, David S; Liu, Chunming (2016) Multifaceted roles for thymine DNA glycosylase in embryonic development and human carcinogenesis. Acta Biochim Biophys Sin (Shanghai) 48:82-9
Wagner, Jonathan M; Chan, Sum; Evans, Timothy J et al. (2016) Structures of EccB1 and EccD1 from the core complex of the mycobacterial ESX-1 type VII secretion system. BMC Struct Biol 16:5
Sviripa, Vitaliy M; Burikhanov, Ravshan; Obiero, Josiah M et al. (2016) Par-4 secretion: stoichiometry of 3-arylquinoline binding to vimentin. Org Biomol Chem 14:74-84
Frasinyuk, Mykhaylo S; Mrug, Galyna P; Bondarenko, Svitlana P et al. (2016) Antineoplastic Isoflavonoids Derived from Intermediate ortho-Quinone Methides Generated from Mannich Bases. ChemMedChem 11:600-11
Kwiatkowski, Stefan; Sviripa, Vitaliy M; Zhang, Zhaiyi et al. (2016) Synthesis of a norcantharidin-tethered guanosine: Protein phosphatase-1 inhibitors that change alternative splicing. Bioorg Med Chem Lett 26:965-8
Riedmann, Caitlyn; Fondufe-Mittendorf, Yvonne N (2016) Comparative analysis of linker histone H1, MeCP2, and HMGD1 on nucleosome stability and target site accessibility. Sci Rep 6:33186
Falaleeva, Marina; Surface, Justin; Shen, Manli et al. (2015) SNORD116 and SNORD115 change expression of multiple genes and modify each other's activity. Gene 572:266-73
Kril, Liliia M; Vilchez, Valery; Jiang, Jieyun et al. (2015) N-Aryl benzenesulfonamide inhibitors of [3H]-thymidine incorporation and β-catenin signaling in human hepatocyte-derived Huh-7 carcinoma cells. Bioorg Med Chem Lett 25:3897-9

Showing the most recent 10 out of 26 publications